Mouse Anti-KCNC2 Recombinant Antibody (A733) (CBMAB-AP11266LY)

Seiffert, S., Pendziwiat, M., Hedrich, U., Helbig, I., Weber, Y., & Schwarz, N. (2023). KCNC2 variants of uncertain significance are also associated to various forms of epilepsy. Frontiers in Neurology, 14, 1212079.

Huo, L., Wu, Q., Yang, F., Liu, X., Yang, Z., & Wang, H. (2023). Novel KCNC2 variant associated with developmental and epileptic encephalopathy. International Journal of Developmental Neuroscience.

Wang, S., Yu, Y., Wang, X., Deng, X., Ma, J., Liu, Z., ... & Sun, D. (2022). Emerging evidence of genotype–phenotype associations of developmental and epileptic encephalopathy due to KCNC2 mutation: Identification of novel R405G. Frontiers in Molecular Neuroscience, 15, 950255.

Li, L., Liu, Z., Yang, H., Li, Y., Zeng, Q., Chen, L., ... & Shen, X. (2022). Investigation of novel de novo KCNC2 variants causing severe developmental and early-onset epileptic encephalopathy. Seizure, 101, 218-224.

Schwarz, N., Seiffert, S., Pendziwiat, M., Rademacher, A. V., Brünger, T., Hedrich, U. B., ... & Weber, Y. (2022). Spectrum of phenotypic, genetic, and functional characteristics in patients with epilepsy with KCNC2 pathogenic variants. Neurology, 98(20), e2046-e2059.

Mehinovic, E., Gray, T., Campbell, M., Ekholm, J., Wenger, A., Rowell, W., ... & Turner, T. N. (2022). Germline mosaicism of a missense variant in KCNC2 in a multiplex family with autism and epilepsy characterized by long‐read sequencing. American Journal of Medical Genetics Part A, 188(7), 2071-2081.

Mukherjee, S., Cassini, T. A., Hu, N., Yang, T., Li, B., Shen, W., ... & Capra, J. A. (2022). Personalized structural biology reveals the molecular mechanisms underlying heterogeneous epileptic phenotypes caused by de novo KCNC2 variants. Human Genetics and Genomics Advances, 3(4).

Rydzanicz, M., Zwoliński, P., Gasperowicz, P., Pollak, A., Kostrzewa, G., Walczak, A., ... & Płoski, R. (2021). A recurrent de novo variant supports KCNC2 involvement in the pathogenesis of developmental and epileptic encephalopathy. American Journal of Medical Genetics Part A, 185(11), 3384-3389.

Vetri, L., Calì, F., Vinci, M., Amato, C., Roccella, M., Granata, T., ... & Elia, M. (2020). A de novo heterozygous mutation in KCNC2 gene implicated in severe developmental and epileptic encephalopathy. European Journal of Medical Genetics, 63(4), 103848.

Rademacher, A., Seiffert, S., Pendziwiat, M., Rohr, A., van Baalen, A., & Helbig, I. (2020). Whole-exome sequencing in NF1-related west syndrome leads to the identification of KCNC2 as a novel candidate gene for epilepsy. Neuropediatrics, 51(05), 368-372.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols